Antares Pharma (ATRS) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ATRS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Antares Pharma Short Interest DataCurrent Short Volume4,780,000 sharesPrevious Short Volume7,280,000 sharesChange Vs. Previous Month-34.34%Dollar Volume Sold Short$26.62 millionShort Interest Ratio / Days to Cover1.0Last Record DateMay 15, 2022Outstanding Shares170,852,000 sharesFloat Size165,700,000 sharesShort Percent of Float2.88%Today's Trading Volume6 sharesAverage Trading Volume3,291,313 sharesToday's Volume Vs. Average0% Short Selling Antares Pharma ? Sign up to receive the latest short interest report for Antares Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATRS Short Interest Over TimeATRS Days to Cover Over TimeATRS Percentage of Float Shorted Over Time Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" Antares Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20224,780,000 shares $26.62 million -34.3%2.9%1 $5.57 4/30/20227,280,000 shares $40.51 million +86.2%4.4%1.7 $5.57 4/15/20223,910,000 shares $21.74 million -3.2%2.4%1.1 $5.56 3/31/20224,040,000 shares $16.56 million -10.0%2.5%5.1 $4.10 3/15/20224,490,000 shares $17.11 million +9.0%2.7%6.1 $3.81 2/28/20224,120,000 shares $14.42 million +2.5%2.5%5.7 $3.50 Get the Latest News and Ratings for ATRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Antares Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/20224,020,000 shares $14.91 million +15.5%2.4%6 $3.71 1/31/20223,480,000 shares $11.73 million +3.6%2.1%5 $3.37 1/15/20223,360,000 shares $12.00 million +2.8%2.0%5 $3.57 12/31/20213,270,000 shares $11.67 million +18.1%2.0%5 $3.57 12/15/20212,770,000 shares $9.03 million +10.8%1.7%4.2 $3.26 11/30/20212,500,000 shares $8.08 million -6.0%1.5%4.1 $3.23 11/15/20212,660,000 shares $9.58 million -34.2%1.6%4.4 $3.60 10/29/20214,040,000 shares $15.11 million +0.5%2.5%6.5 $3.74 10/15/20214,020,000 shares $13.87 million -11.5%2.4%6.8 $3.45 9/30/20214,540,000 shares $16.53 million No Change2.8%7.3 $3.64 9/15/20214,540,000 shares $16.57 million -1.3%2.8%6.9 $3.65 8/31/20214,600,000 shares $18.12 million +9.3%2.8%6.4 $3.94 8/13/20214,210,000 shares $16.46 million -3.2%2.6%5.1 $3.91 7/30/20214,350,000 shares $19.14 million -4.6%2.6%5.2 $4.40 7/15/20214,560,000 shares $18.79 million -0.7%2.8%5.5 $4.12 6/30/20214,590,000 shares $20.01 million -16.7%2.8%5.5 $4.36 6/15/20215,510,000 shares $22.81 million -7.9%3.4%6.7 $4.14 5/28/20215,980,000 shares $23.74 million +3.8%3.6%7.2 $3.97 5/14/20215,760,000 shares $21.95 million +0.2%N/A5.8 $3.81 4/30/20215,750,000 shares $22.20 million +2.9%N/A5.1 $3.86 4/15/20215,590,000 shares $22.70 million +14.3%3.6%4.7 $4.06 3/31/20214,890,000 shares $19.71 million -1.0%3.2%3.8 $4.03 3/15/20214,940,000 shares $22.43 million +20.5%3.2%3.6 $4.54 2/26/20214,100,000 shares $18.33 million +4.6%2.7%2.8 $4.47 2/12/20213,920,000 shares $18.19 million +2.9%2.6%3 $4.64 1/29/20213,810,000 shares $16.73 million -0.8%2.5%3.3 $4.39 1/15/20213,840,000 shares $16.67 million -3.5%2.5%3.4 $4.34 12/31/20203,980,000 shares $16.04 million +6.1%2.6%3.7 $4.03 12/15/20203,750,000 shares $14.01 million -5.1%2.5%3.7 $3.74 11/30/20203,950,000 shares $12.32 million -3.7%2.6%4.4 $3.12 11/15/20204,100,000 shares $11.69 million +1.2%2.7%4.7 $2.85 10/30/20204,050,000 shares $11.34 million +4.4%2.6%4.6 $2.80 10/15/20203,880,000 shares $12.98 million -7.0%2.5%4.3 $3.35 9/30/20204,170,000 shares $11.26 million -13.5%2.7%4.6 $2.70The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him ATRS Short Interest - Frequently Asked Questions What is Antares Pharma's current short interest? Short interest is the volume of Antares Pharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 4,780,000 shares of ATRS short. 2.88% of Antares Pharma's shares are currently sold short. Learn More on Antares Pharma's current short interest. What is a good short interest ratio for Antares Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATRS shares currently have a short interest ratio of 1.0. Learn More on Antares Pharma's short interest ratio. What is a good short interest percentage for Antares Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.88% of Antares Pharma's floating shares are currently sold short. Is Antares Pharma's short interest increasing or decreasing? Antares Pharma saw a decline in short interest in May. As of May 15th, there was short interest totaling 4,780,000 shares, a decline of 34.3% from the previous total of 7,280,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Antares Pharma's float size? Antares Pharma currently has issued a total of 170,852,000 shares. Some of Antares Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Antares Pharma currently has a public float of 165,700,000 shares. How does Antares Pharma's short interest compare to its competitors? 2.88% of Antares Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Antares Pharma: Atrion Co. (7.13%), OraSure Technologies, Inc. (4.21%), Anika Therapeutics, Inc. (5.44%), Cerus Co. (3.24%), Utah Medical Products, Inc. (1.65%), Accuray Incorporated (5.31%), Cytosorbents Co. (2.98%), ICU Medical, Inc. (4.71%), MiMedx Group, Inc. (4.98%), Artivion, Inc. (7.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.79 billion), Palo Alto Networks, Inc. ($3.41 billion), Lucid Group, Inc. ($2.55 billion), Uber Technologies, Inc. ($2.21 billion), HP Inc. ($2.14 billion), T. Rowe Price Group, Inc. ($1.81 billion), Coinbase Global, Inc. ($1.60 billion), Take-Two Interactive Software, Inc. ($1.58 billion), Lumen Technologies, Inc. ($1.56 billion), and Rivian Automotive, Inc. ($1.55 billion). View all of the most shorted stocks. What does it mean to sell short Antares Pharma stock? Short selling ATRS is an investing strategy that aims to generate trading profit from Antares Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Antares Pharma? A short squeeze for Antares Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRS, which in turn drives the price of the stock up even further. How often is Antares Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRS, twice per month. The most recent reporting period available is May, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Atrion Short Interest OraSure Technologies Short Interest Anika Therapeutics Short Interest Cerus Short Interest Utah Medical Products Short Interest Accuray Short Interest Cytosorbents Short Interest ICU Medical Short Interest MiMedx Group Short Interest Artivion Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATRS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport SocietyGreat Crypto BullWeiss Ratings